Ey, J., Schomig, E., and Taubert, D. Dietary sources and antioxidant effects of ergothioneine. J Agric Food Chem 8-8-2007;55(16):6466-6474. View abstract.
Smiles, K. A., Dong, K. K., Canning, M. T., Grimson, R., Walfield, A. M., and Yarosh, D. B. A hydroquinone formulation with increased stability and decreased potential for irritation. J Cosmet.Dermatol 2007;6(2):83-88. View abstract.
Urban, T. J., Yang, C., Lagpacan, L. L., Brown, C., Castro, R. A., Taylor, T. R., Huang, C. C., Stryke, D., Johns, S. J., Kawamoto, M., Carlson, E. J., Ferrin, T. E., Burchard, E. G., and Giacomini, K. M. Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4). Pharmacogenet.Genomics 2007;17(9):773-782. View abstract.
Benson KF, Ager DM, Landes B, Aruoma OI, Jensen GS. Improvement of joint range of motion (ROM) and reduction of chronic pain after consumption of an ergothioneine-containing nutritional supplement. Prev Med. 2012;54 Suppl:S83-9. View abstract.
Cargnoni A, Bernocchi P, Ceconi C, et al. In vitro administration of ergothioneine failed to protect isolated ischaemic and reperfused rabbit heart. Biochim Biophys Acta 1995;1270:173-8. View abstract.
Cheah IK, Tang RM, Yew TS, Lim KH, Halliwell B. Administration of pure ergothioneine to healthy human subjects: Uptake, metabolism, and effects on biomarkers of oxidative damage and inflammation. Antioxid Redox Signal. 2017;26(5):193-206. View abstract.
Deiana M, Rosa A, Casu V, et al. L-ergothioneine modulates oxidative damage in the kidney and liver of rats in vivo: studies upon the profile of polyunsaturated fatty acids. Clin Nutr 2004;23:183-93. View abstract.
Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
Forster R, Spézia F, Papineau D, et al. Reproductive safety evaluation of L-Ergothioneine. Food Chem Toxicol. 2015;80:85-91. View abstract.
Franzoni F, Colognato R, Galetta F, et al. An in vitro study on the free radical scavenging capacity of ergothioneine: comparison with reduced glutathione, uric acid and trolox. Biomed Pharmacother 2006;60:453-7. View abstract.
Grundemann D, Harlfinger S, Golz S, et al. Discovery of the ergothioneine transporter. Proc Natl Acad Sci U S A 2005;102:5256-61. View abstract.
Guijarro MV, Indart A, Aruoma OI, et al. Effects of ergothioneine on diabetic embryopathy in pregnant rats. Food Chem Toxicol 2002;40:1751-5. View abstract.
Jang JH, Aruoma OI, Jen LS, et al. Ergothioneine rescues PC12 cells from beta-amyloid-induced apoptotic death. Free Radic Biol Med 2004;36:288-99. View abstract.
Mitsuyama H, May JM. Uptake and antioxidant effects of ergothioneine in human erythrocytes. Clin Sci (Lond) 1999;97:407-11. View abstract.
Moncaster JA, Walsh DT, Gentleman SM, et al. Ergothioneine treatment protects neurons against N-methyl-D-aspartate excitotoxicity in an in vivo rat retinal model. Neurosci Lett 2002;328:55-9. View abstract.
Nishida K, Takeuchi K, Hosoda A, et al. Ergothioneine ameliorates oxaliplatin-induced peripheral neuropathy in rats. Life Sci 2018;207:516-24. View abstract.
Rahman I, Gilmour PS, Jimenez LA, et al. Ergothioneine inhibits oxidative stress- and TNF-alpha-induced NF-kappa B activation and interleukin-8 release in alveolar epithelial cells. Biochem Biophys Res Commun 2003;302:860-4. View abstract.
Sakrak O, Kerem M, Bedirli A, et al. Ergothioneine modulates proinflammatory cytokines and heat shock protein 70 in mesenteric ischemia and reperfusion injury. J Surg Res 2008;144:36-42. View abstract.
Smith E, Ottosson F, Hellstrand S, et al. Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease. Heart 2019. pii: heartjnl-2019-315485.View abstract.